| Literature DB >> 34306065 |
Nicholas Cothros1, Alex Medina1, Davide Martino2, Sean P Dukelow1, Rachel L Hawe2, Adam Kirton3, Christos Ganos4, Elaheh Nosratmirshekarlou1, Tamara Pringsheim5.
Abstract
Background: Tic disorders may reflect impaired inhibitory control. This has been evaluated using different behavioural tasks, yielding mixed results. Our objective was to test inhibitory control in children with tics through simultaneous presentation of multiple, mobile stimuli.Entities:
Mesh:
Year: 2021 PMID: 34306065 PMCID: PMC8270726 DOI: 10.1155/2021/8825091
Source DB: PubMed Journal: Neural Plast ISSN: 1687-5443 Impact factor: 3.599
Participant demographic variables.
| Controls ( | Tic disorders group ( | Tics without comorbid ADHD ( | Tics with comorbid ADHD ( | |
|---|---|---|---|---|
| Mean age (standard deviation) | 12.99 (4.10) | 12.38 (2.58) | 12.53 (2.70) | 12.38 (2.51) |
| Left-hand dominant (percent of total) | 13/146 (8.9%) | 11/64 (17.19%) | 3/33 (9.09%) | 8/31 (25.81%) |
| Male : female ratio (percent male of total) | 77 : 69 (52.74%) | 60 : 4 (93.75%) | 28 : 5 (84.85%) | 30 : 1 (96.77%) |
|
| ||||
| Comorbidities in tic disorders group | ||||
| Attention-deficit hyperactivity disorder | 31/64 (48%) | |||
| Obsessive-compulsive disorder | 16/64 (25%) | 6/33 (18.18%) | 10/31 (32.26%) | |
| Generalized anxiety disorder | 16/64 (25%) | 8/33 (24.24%) | 8/31 (25.81%) | |
| Depression | 5/64 (7.8%) | 3/33 (9.09%) | 2/31 (6.45%) | |
| Autism spectrum disorder | 5/64 (7.8%) | 1/33 (3.03%) | 4/31 (12.9%) | |
|
| ||||
| Medications for tics in tic disorders group (number of participants and percentage of group) | ||||
| Aripiprazole | 5 (7.81%) | |||
| Clonidine | 4 (6.25%) | |||
| Guanfacine | 4 (6.25%) | |||
| Risperidone | 1 (1.56%) | |||
| Topiramate | 1 (1.56%) | |||
| No medications for tics | 49 (76.56%) | |||
Figure 1Kinarm and object-hit-and-avoid task.
ANCOVA results for each inhibition variable, control participants versus those with tic disorders, with age as covariate; and for control participants versus those with tic disorders, groups are split into two (those without ADHD and those with ADHD), with age as covariate, and planned contrasts comparing each of the two patient groups to the control group.
| Inhibition variables | Controls (adjusted mean and 95% CI) | Tics-without-ADHD |
| Tics-plus-ADHD |
| Between-groups | Post hoc comparisons between patient groups (mean difference and 95% CI for difference) |
|---|---|---|---|---|---|---|---|
| Distractor hits | 15.61% (14.28, 16.95) | 22.71% (19.81, 25.61) | <0.0001 | 23.56% (20.66, 26.46) | <0.0001 |
| -0.085; -5.87, 4.17; |
| Distractor proportion | 11.31% (10.48, 12.15) | 15.99% (14.17, 17.81) | <0.0001 | 16.49% (14.68, 18.31) | <0.0001 |
| -0.50; -3.65, 2.64; |
| Object processing rate | 1.97 (1.93, 2.00) | 1.87 (1.79, 1.95) | 0.032 | 1.83 (1.75, 1.91) | 0.002 |
| -0.05; -0.18, 0.10; |
ANCOVA results for each task-level variable, control participants versus those with tic disorders, with age as covariate; and for control participants versus those with tic disorders, groups are split into two (those without ADHD and those with ADHD), with age as covariate, and planned contrasts comparing each of the two patient groups to the control group.
| Task-level variables | Controls (adjusted mean and 95% CI) | Tics-without-ADHD |
| Tics-plus-ADHD |
| Between-groups | Post hoc comparisons between patient groups (mean difference and 95% CI for difference) |
|---|---|---|---|---|---|---|---|
| Target hits | 126.86 (124.35, 129.36) | 122.66 (117.20, 128.13) | 0.157 | 119.74 (114.28, 125.21) | 0.018 |
| 2.92; -6.536, 12.732; |
| Target hits dominant | 65.87 (60.59, 65.54) | 63.73 (60.15, 67.31) | 0.268 | 62.91 (59.33, 66.48) | 0.130 |
| 0.82; -5.36, 7.011; |
| Target hits nondominant | 60.99 (59.37, 62.60) | 58.93 (55.41, 62.46) | 0.283 | 56.84 (53.31, 60.34) | 0.034 |
| 2.10; -4.01, 8.20; |
ANCOVA results for each kinematic variable, control participants versus those with tic disorders, with age as covariate; and for control participants versus those with tic disorders, groups are split into two (those without ADHD and those with ADHD), with age as covariate, and planned contrasts comparing each of the two patient groups to the control group.
| Kinematic variables | Controls (adjusted mean and 95% CI) | Tics-without-ADHD |
| Tics-plus-ADHD |
| Between-groups | Post hoc comparisons between patient groups (mean difference and 95% CI for difference) |
|---|---|---|---|---|---|---|---|
| Movement speed dominant | 0.183 m/s (0.175, 0.192) | 0.193 m/s (0.175, 0.211) | 0.342 | 0.216 m/s (0.198, 0.234) | 0.001 |
| -0.023; -0.054, 0.010; |
| Movement speed nondominant | 0.173 m/s (0.165, 0.181) | 0.182 m/s (0.166, 0.199) | 0.326 | 0.192 m/s (0.175, 0.209) | 0.047 |
| -0.010; -0.038, 0.019; |
| Movement area dominant | 0.109 m2 (0.104, 0.114) | 0.113 m2 (0.103, 0.123) | 0.497 | 0.120 m2 (0.110, 0.131) | 0.047 |
| -0.010; -0.025, 0.010; |
| Movement area nondominant | 0.100 m2 (0.095, 0.104) | 0.106 m2 (0.096, 0.117) | 0.235 | 0.102 m2 (0.092, 0.112) | 0.650 |
| 0.004; -0.014, 0.022; |
Figure 2Box-and-whisker plots comparing patients without comorbid ADHD with those with comorbid ADHD and controls. In each plot, group 1 denotes patients without comorbid ADHD, group 2 denotes patients with comorbid ADHD, and group 3 denotes controls. Circles represent individuals scoring outside age-predicted norms (black denotes patients without comorbid ADHD; magenta denotes patients with comorbid ADHD). Crosses represent outliers (more than 1.5 times the interquartile range away from the top or bottom of the box). Dots represent each individual participant.
Figure 3Performance on different task parameters as a function of age, comparing patients (those without comorbid ADHD with those with comorbid ADHD) with controls. In each plot, dots represent controls, black circles represent patients without comorbid ADHD, and magenta circles represent patients with comorbid ADHD. Age curves are shown as solid traces, with 95% prediction bands shown as dotted traces.
Figure 4Percentage of patients who scored outside age-predicted norms in the task parameters. Each bar is divided to show patients without comorbid ADHD (in black) and those with comorbid AHDH (in magenta).